• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球 L1 转录组分析鉴定 IGFBP-2 是 ezrin 和 NF-κB 信号的靶标,促进结肠癌的进展。

Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-κB signaling that promotes colon cancer progression.

机构信息

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

出版信息

Oncogene. 2013 Jul 4;32(27):3220-30. doi: 10.1038/onc.2012.340. Epub 2012 Aug 6.

DOI:10.1038/onc.2012.340
PMID:22869145
Abstract

L1, a neuronal cell adhesion receptor of the immunoglobulin-like protein family is expressed in invading colorectal cancer (CRC) cells as a target gene of Wnt/β-catenin signaling. Overexpression of L1 in CRC cells enhances cell motility and proliferation, and confers liver metastasis. We recently identified ezrin and the IκB-NF-κB pathway as essential for the biological properties conferred by L1 in CRC cells. Here, we studied the underlying molecular mechanisms and found that L1 enhances ezrin phosphorylation, via Rho-associated protein kinase (ROCK), and is required for L1-ezrin co-localization at the juxtamembrane domain and for enhancing cell motility. Global transcriptomes from L1-expressing CRC cells were compared with transcriptomes from the same cells expressing small hairpin RNA (shRNA) to ezrin. Among the genes whose expression was elevated by L1 and ezrin we identified insulin-like growth factor-binding protein 2 (IGFBP-2) and showed that its increased expression is mediated by an NF-κB-mediated transactivation of the IGFBP-2 gene promoter. Expression of a constitutively activated mutant ezrin (Ezrin567D) could also increase IGFBP-2 levels in CRC cells. Overexpression of IGFBP-2 in CRC cells lacking L1-enhanced cell proliferation (in the absence of serum), cell motility, tumorigenesis and induced liver metastasis, similar to L1 overexpression. Suppression of endogenous IGFBP-2 in L1-transfected cells inhibited these properties conferred by L1. We detected IGFBP-2 in a unique organization at the bottom of human colonic crypts in normal mucosa and at increased levels throughout human CRC tissue samples co-localizing with the phosphorylated p65 subunit of NF-κB. Finally, we found that IGFBP-2 and L1 can form a molecular complex suggesting that L1-mediated signaling by the L1-ezrin-NF-κB pathway, that induces IGFBP-2 expression, has an important role in CRC progression.

摘要

L1 是免疫球蛋白样蛋白家族的一种神经元细胞粘附受体,作为 Wnt/β-catenin 信号的靶基因在侵袭性结直肠癌 (CRC) 细胞中表达。CRC 细胞中 L1 的过表达增强了细胞的迁移和增殖能力,并赋予了肝转移的能力。我们最近确定了 ezrin 和 IκB-NF-κB 途径是 L1 在 CRC 细胞中赋予这些生物学特性所必需的。在这里,我们研究了潜在的分子机制,发现 L1 通过 Rho 相关蛋白激酶 (ROCK) 增强 ezrin 的磷酸化,并需要 L1-ezrin 在质膜附近区域的共定位以及增强细胞迁移。与表达小发夹 RNA (shRNA) 到 ezrin 的相同细胞的转录组进行比较,从表达 L1 的 CRC 细胞中获得了全局转录组。在 L1 和 ezrin 上调的基因中,我们鉴定出胰岛素样生长因子结合蛋白 2 (IGFBP-2),并表明其表达增加是由 IGFBP-2 基因启动子的 NF-κB 介导的转录激活介导的。组成型激活突变体 ezrin (Ezrin567D) 的表达也可以增加 CRC 细胞中的 IGFBP-2 水平。在缺乏 L1 增强的细胞增殖(在没有血清的情况下)、细胞迁移、肿瘤发生和诱导肝转移的情况下,CRC 细胞中 IGFBP-2 的过表达也可以增加这些特性,类似于 L1 的过表达。在转染 L1 的细胞中抑制内源性 IGFBP-2 抑制了 L1 赋予的这些特性。我们在正常黏膜的人结肠隐窝底部检测到 IGFBP-2 的独特组织,并在整个人 CRC 组织样本中检测到 IGFBP-2 的水平增加,与磷酸化的 p65 亚单位 NF-κB 共定位。最后,我们发现 IGFBP-2 和 L1 可以形成一个分子复合物,表明 L1 通过 L1-ezrin-NF-κB 途径介导的信号,诱导 IGFBP-2 的表达,在 CRC 进展中具有重要作用。

相似文献

1
Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-κB signaling that promotes colon cancer progression.全球 L1 转录组分析鉴定 IGFBP-2 是 ezrin 和 NF-κB 信号的靶标,促进结肠癌的进展。
Oncogene. 2013 Jul 4;32(27):3220-30. doi: 10.1038/onc.2012.340. Epub 2012 Aug 6.
2
Nuclear factor-kappaB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells.核因子-κB 信号通路和埃兹蛋白对于结肠癌 L1 介导的转移是必需的。
J Cell Sci. 2010 Jun 15;123(Pt 12):2135-43. doi: 10.1242/jcs.069542. Epub 2010 May 25.
3
The Collagen-Modifying Enzyme PLOD2 Is Induced and Required during L1-Mediated Colon Cancer Progression.胶原修饰酶 PLOD2 在 L1 介导的结肠癌进展过程中被诱导并需要其发挥作用。
Int J Mol Sci. 2021 Mar 29;22(7):3552. doi: 10.3390/ijms22073552.
4
A point mutation in the extracellular domain of L1 blocks its capacity to confer metastasis in colon cancer cells via CD10.L1细胞外结构域中的一个点突变通过CD10阻断了其赋予结肠癌细胞转移能力。
Oncogene. 2017 Mar;36(11):1597-1606. doi: 10.1038/onc.2016.329. Epub 2016 Sep 19.
5
c-Kit is suppressed in human colon cancer tissue and contributes to L1-mediated metastasis.c-Kit 在人结肠癌组织中受到抑制,并促进 L1 介导的转移。
Cancer Res. 2013 Sep 15;73(18):5754-63. doi: 10.1158/0008-5472.CAN-13-0576. Epub 2013 Sep 5.
6
Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression.诱导肠道干细胞标志性基因SMOC-2是L1介导的结肠癌进展所必需的。
Oncogene. 2016 Feb 4;35(5):549-57. doi: 10.1038/onc.2015.127. Epub 2015 Apr 27.
7
A Necessary Role for Increased Biglycan Expression during L1-Mediated Colon Cancer Progression.L1 介导的结肠癌进展过程中 BIGLYCAN 表达增加的必要性作用。
Int J Mol Sci. 2021 Dec 31;23(1):445. doi: 10.3390/ijms23010445.
8
Clusterin, a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis.聚集素是一种在肠道干细胞中富集的基因,是L1介导的结肠癌转移所必需的。
Oncotarget. 2015 Oct 27;6(33):34389-401. doi: 10.18632/oncotarget.5360.
9
L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers.L1 介导的结肠癌转移不需要 EMT 和癌症干细胞标志物的改变。
Mol Cancer Res. 2011 Jan;9(1):14-24. doi: 10.1158/1541-7786.MCR-10-0406. Epub 2010 Dec 1.
10
The intestinal stem cell regulating gene ASCL2 is required for L1-mediated colon cancer progression.肠干细胞调控基因 ASCL2 是 L1 介导的结肠癌进展所必需的。
Cancer Lett. 2018 Jun 28;424:9-18. doi: 10.1016/j.canlet.2018.03.022. Epub 2018 Mar 15.

引用本文的文献

1
Improving data interpretability with new differential sample variance gene set tests.使用新的差异样本方差基因集检验提高数据的可解释性。
BMC Bioinformatics. 2025 Apr 14;26(1):103. doi: 10.1186/s12859-025-06117-0.
2
Diagnostic Accuracy of a Blood-Based Biomarker Panel for Colorectal Cancer Detection: A Pilot Study.基于血液的生物标志物检测板用于结直肠癌检测的诊断准确性:一项初步研究。
Cancers (Basel). 2024 Dec 15;16(24):4176. doi: 10.3390/cancers16244176.
3
A Necessary Role for Cyclin D2 Induction During Colon Cancer Progression Mediated by L1.
L1 介导的结肠癌进展过程中细胞周期蛋白 D2 诱导的必然作用
Cells. 2024 Nov 2;13(21):1810. doi: 10.3390/cells13211810.
4
Improving data interpretability with new differential sample variance gene set tests.使用新的差异样本方差基因集测试提高数据可解释性。
Res Sq. 2024 Sep 9:rs.3.rs-4888767. doi: 10.21203/rs.3.rs-4888767/v1.
5
Mechanisms and Consequences of Variable TRPA1 Expression by Airway Epithelial Cells: Effects of Genotype and Environmental Agonists on Cellular Responses to Pollutants and Asthma.气道上皮细胞中 TRPA1 表达的可变机制和后果:基因型和环境激动剂对细胞对污染物和哮喘反应的影响。
Environ Health Perspect. 2023 Feb;131(2):27009. doi: 10.1289/EHP11076. Epub 2023 Feb 27.
6
Downregulation of the Tumor Suppressor TFF1 Is Required during Induction of Colon Cancer Progression by L1.在L1诱导结肠癌进展过程中,肿瘤抑制因子TFF1的下调是必需的。
Cancers (Basel). 2022 Sep 15;14(18):4478. doi: 10.3390/cancers14184478.
7
WNT/beta-catenin signalling interrupts a senescence-induction cascade in human mesenchymal stem cells that restricts their expansion.WNT/β-连环蛋白信号中断了人骨髓间充质干细胞中的衰老诱导级联反应,从而限制了它们的扩增。
Cell Mol Life Sci. 2022 Jan 20;79(2):82. doi: 10.1007/s00018-021-04035-x.
8
A Necessary Role for Increased Biglycan Expression during L1-Mediated Colon Cancer Progression.L1 介导的结肠癌进展过程中 BIGLYCAN 表达增加的必要性作用。
Int J Mol Sci. 2021 Dec 31;23(1):445. doi: 10.3390/ijms23010445.
9
Insulin-like Growth Factor Binding Protein-2 (IGFBP2) Is a Key Molecule in the MACC1-Mediated Platelet Communication and Metastasis of Colorectal Cancer Cells.胰岛素样生长因子结合蛋白-2(IGFBP2)是 MACC1 介导的血小板通讯和结直肠癌细胞转移的关键分子。
Int J Mol Sci. 2021 Nov 11;22(22):12195. doi: 10.3390/ijms222212195.
10
Anticancer properties of dried-pericarp water extracts of Camellia japonica L. fermented with Aspergillus oryzae through regulation of IGFBP-2/mTOR pathway.经米曲霉发酵的山茶花干果皮水提物通过调控 IGFBP-2/mTOR 通路的抗癌作用。
Sci Rep. 2021 Nov 2;11(1):21527. doi: 10.1038/s41598-021-01127-3.